Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/27/1999 | CA2311238A1 Method for unbiased mrna amplification |
05/27/1999 | CA2310624A1 Chimeric pre-activated transcription factors |
05/27/1999 | CA2310563A1 Vector for tissue-specific replication and gene expression |
05/27/1999 | CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity |
05/27/1999 | CA2310228A1 Attaching substances to micro-organisms |
05/27/1999 | CA2310215A1 Methods and compositions for the treatment of psoriasis |
05/27/1999 | CA2310016A1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
05/27/1999 | CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response |
05/27/1999 | CA2309927A1 Oligonucleotide synthesis using high boiling point solvents |
05/27/1999 | CA2309904A1 Transfection and transfer of male germ cells for generation of transgenic species |
05/27/1999 | CA2309886A1 Cellulase produced by actinomycetes and method of producing same |
05/27/1999 | CA2309885A1 Recombinant allergen with reduced enzymatic activity |
05/27/1999 | CA2309880A1 Chimera gene having a light dependent promoter providing tolerance to hppd inhibitors |
05/27/1999 | CA2309835A1 Alphavirus vectors |
05/27/1999 | CA2309826A1 Alphavirus vectors for paramyxovirus vaccines |
05/27/1999 | CA2309807A1 Transgenic models of inflammatory disease |
05/27/1999 | CA2309764A1 Cellulase produced by actinomycetes and method for producing same |
05/27/1999 | CA2309763A1 Variable region fusion peptides that form effector complexes in the presence of antigen |
05/27/1999 | CA2309761A1 Th2 cell depletion; compositions; methods |
05/27/1999 | CA2309758A1 Reagents and methods useful for detecting diseases of the breast |
05/27/1999 | CA2309757A1 Stress resistance gene |
05/27/1999 | CA2309754A1 Regulation of fungal gene expression |
05/27/1999 | CA2309719A1 Targeted manipulation of genes in plants |
05/27/1999 | CA2309390A1 Cdk2 protein and cdk2 protein complexes |
05/27/1999 | CA2309387A1 Method and kit for determining severe inflammatory reactions to mosquito bites |
05/27/1999 | CA2309343A1 Toso |
05/27/1999 | CA2309339A1 Transcriptionally regulated g protein-coupled receptor |
05/27/1999 | CA2309336A1 Neuralized protein, polynucleotide encoding the same, and antibody recognizing the same |
05/27/1999 | CA2309000A1 Tc1-based transposon vectors |
05/27/1999 | CA2308571A1 Single-chain bifunctional glycoprotein hormones |
05/27/1999 | CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog |
05/27/1999 | CA2307539A1 Improvements relating to protein accumulation |
05/27/1999 | CA2306776A1 Methods for modulating nerve cell function |
05/27/1999 | CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods |
05/27/1999 | CA2305866A1 A method for directional stable transformation of eukaryotic cells |
05/27/1999 | CA2302644A1 Extended cdnas for secreted proteins |
05/27/1999 | CA2282811A1 Expression cloning processes for the discovery, characterization and isolation of genes encoding polypeptides with a predetermined property |
05/27/1999 | CA2277804A1 Production of a lampbrush chromosome |
05/26/1999 | EP0918091A1 A gene called XLIS and the XLIS gene product, called doublecortin and their applications |
05/26/1999 | EP0917591A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method |
05/26/1999 | EP0917586A1 Vector for activating the immune system against cells associated to papilloma viruses or sequences thereof |
05/26/1999 | EP0917585A2 Vectors for delivering viral and oncogenic inhibitors |
05/26/1999 | EP0917584A1 Modified tomato mottle geminivirus coat protein gene |
05/26/1999 | EP0917583A2 Maize promoter sequence for leaf- and stalk-preferred gene expression |
05/26/1999 | EP0917582A2 Genomic sequence of rhizobium sp. ngr 234 symbiotic plasmid |
05/26/1999 | EP0917581A1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
05/26/1999 | EP0917580A1 DEFORMYLATION OF f-MET PEPTIDES IN BACTERIAL EXPRESSION SYSTEMS |
05/26/1999 | EP0917579A1 Vertebrate telomerase genes and proteins and uses thereof |
05/26/1999 | EP0917578A1 NOVEL STRAINS OF $i(ESCHERICHIA COLI), METHODS OF PREPARING THE SAME AND USE THEREOF IN FERMENTATION PROCESSES FOR L-THREONINE PRODUCTION |
05/26/1999 | EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis |
05/26/1999 | EP0917576A1 Anti-herpesviral agents and assays therefor |
05/26/1999 | EP0917575A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection |
05/26/1999 | EP0917574A2 BCL-x$g(g), A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO |
05/26/1999 | EP0917573A2 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system |
05/26/1999 | EP0917572A2 Secreted proteins and polynucleotides encoding them |
05/26/1999 | EP0917571A1 Agouti-related gene |
05/26/1999 | EP0917570A2 Mhc binding peptide oligomers and methods of use |
05/26/1999 | EP0917569A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
05/26/1999 | EP0917567A1 Plasminogen activator capable of being activated by thrombin |
05/26/1999 | EP0917566A1 Recombinant blood-coagulation proteases |
05/26/1999 | EP0917564A2 Phosphate starvation-inducible proteins |
05/26/1999 | EP0917563A2 Micro-organism which can desulphurise benzothiophenes |
05/26/1999 | EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100 |
05/26/1999 | EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
05/26/1999 | EP0917536A2 Polynucleotide and its use for modulating a defence response in plants |
05/26/1999 | EP0917535A1 Neuroactive peptide |
05/26/1999 | EP0917471A2 Treatment and diagnosis of infections of gram positive cocci |
05/26/1999 | EP0833835A4 Obesity protein intermediates and their preparation and use |
05/26/1999 | EP0832278A4 Linked linear amplification of nucleic acids |
05/26/1999 | EP0804731B1 Method and apparatus for fabricating microarrays of biological samples |
05/26/1999 | EP0781293A4 Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
05/26/1999 | EP0777412A4 FbLATE PROMOTER |
05/26/1999 | EP0741749B1 Mercury binding polypeptides and nucleotides coding therefor |
05/26/1999 | EP0710296A4 Linked linear amplification of nucleic acids |
05/26/1999 | EP0668910B1 Human neuropeptide y-y1 receptor |
05/26/1999 | EP0616641B1 Humanized b-b10, an anti-il2 receptor antibody |
05/26/1999 | EP0589993B1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
05/26/1999 | EP0453560B1 Localization and characterization of the wilms' tumor gene |
05/26/1999 | CN1217751A Parapoxvirus vectors |
05/26/1999 | CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system |
05/26/1999 | CN1217749A DNA fragments containing biotin biosynthesizing gene and use of same |
05/26/1999 | CN1217748A Transferrin receptor genes of moraxella |
05/26/1999 | CN1217746A Pluripotent rabbit embryonic stem (ES) cell lines and their use in generation of chimeric rabbits |
05/26/1999 | CN1217724A Recombination preparation of calcitonia fragments and use thereof in preparation of same and the like |
05/26/1999 | CN1217632A Method of protein production using mitochondrial translation system |
05/26/1999 | CN1217384A Method for breeding quick-growth transgenosis animals |
05/26/1999 | CN1217342A Colony stimulating factor for recombination of human granulocytes and medicinal composition thereof |
05/26/1999 | CN1217339A Cellulose binding domain |
05/26/1999 | CN1217335A Method for preparing precursor medicine |
05/26/1999 | CA2224845A1 Improved forages |
05/25/1999 | US5907086 Plant promoter sequences |
05/25/1999 | US5907085 Grapevine leafroll virus proteins and their uses |
05/25/1999 | US5907084 Virus resistant or tolerant cells |
05/25/1999 | US5907083 Brassica sp. gene promoter highly expressed during stigma development |
05/25/1999 | US5907082 Ovule-specific gene expression |
05/25/1999 | US5907081 Control of plant abscission and pod dehiscence |
05/25/1999 | US5907080 Method for development of transgenic dwarf goats |
05/25/1999 | US5907079 MSH2 disrupted mice develop lymphomas |
05/25/1999 | US5907078 In vivo model systems that adequately reproduce the spectrum of benign, latent, aggressive and metastatic forms of the human disease. |
05/25/1999 | US5907034 With same affinity to ethylenediamine tetraacetic acid and diethylenetriamine pentaacetic acid as to their complexes with manganese, cadmium, zinc, copper, yttrium, or lead |